Beverly Meadows
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Geriatrics and Gerontology top 10%
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 10
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Susan E. Bates (11 shared papers)Tito Fojo (7 shared papers)Robert W. Robey (8 shared papers)Susan Bakke (6 shared papers)Barry R. Goldspiel (6 shared papers)Tom Smith (5 shared papers)Maria Merino (4 shared papers)Joanna Regis (2 shared papers)
- Journals
- Blood (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Cancer (2 papers)CIN Computers Informatics Nursing (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesIsraelItaly
In The Last Decade
Beverly Meadows
15 papers receiving 632 citations
Peers
Comparison fields: 5 of 63
- Oncology 383
- Geriatrics and Gerontology 26
- Pediatrics, Perinatology and Child Health 141
- Occupational Therapy 24
- Cancer Research 65
Countries citing papers authored by Beverly Meadows
This map shows the geographic impact of Beverly Meadows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Meadows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Meadows more than expected).
Fields of papers citing papers by Beverly Meadows
This network shows the impact of papers produced by Beverly Meadows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Meadows. The network helps show where Beverly Meadows may publish in the future.
Co-authors
The 25 scholars most cited alongside Beverly Meadows, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 97 | |
| 2 | 2002 | 89 | |
| 3 | Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi. | 1997 | 87 |
| 4 | 2001 | 70 | |
| 5 | 2001 | 69 | |
| 6 | 1999 | 60 | |
| 7 | 2004 | 58 | |
| 8 | 1995 | 42 | |
| 9 | 1995 | 22 | |
| 10 | Chemoresistance in the clinic: overview 1994. | 1994 | 22 |
| 11 | 1997 | 20 | |
| 12 | 2003 | 7 | |
| 13 | 1999 | 6 | |
| 14 | 1995 | 3 | |
| 15 | 2002 | 2 |
About Beverly Meadows
Beverly Meadows is a scholar working on Oncology, Infectious Diseases, Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 15 papers that have together received 654 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), HIV/AIDS drug development and treatment (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Glycosylation and Glycoproteins Research (1 paper), Business Process Modeling and Analysis (1 paper) and Safe Handling of Antineoplastic Drugs (1 paper). The work is most often cited by research in Oncology (383 citations), Geriatrics and Gerontology (26 citations), Pediatrics, Perinatology and Child Health (141 citations), Occupational Therapy (24 citations) and Cancer Research (65 citations). Beverly Meadows has collaborated with scholars based in United States, Israel and Italy. Frequent co-authors include Susan E. Bates, Tito Fojo, Robert W. Robey, Susan Bakke, Barry R. Goldspiel, Tom Smith, Maria Merino, Joanna Regis, Seth M. Steinberg and William D. Figg. Their work appears in journals such as Blood, Cancer Chemotherapy and Pharmacology, Cancer, CIN Computers Informatics Nursing and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.